Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

   141,861,898      
Direct Value   $82,119,756    

Indirect Value

   $12,961,771,173      
Total Shares   142,789,105      
Total Value   $13,043,890,929      


Incyte Corp $32,589,847 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $312,474 Neurogene $16,634 Incyte Corp $32,589,847 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $312,474 Neurogene $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    36   
    6    

     Stock price went up :
    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    1397         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 56
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
GHDX Genomic Health Inc Director   –       •       •   2007-05-21 4 B $15.50 $16 I/I 1 60,958 2.17 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-22 4 B $6.92 $7 I/I 1 191,337 1.42 -
INCY Incyte Corp Director   –       •       •   2008-01-22 4 B $10.62 $11 I/I 1 282,044 2.17 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2007-12-12 4 S $12.25 $37 I/I (3) 30,402 0 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2008-01-07 4 S $13.00 $39 I/I (3) 28,805 0 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2008-01-08 4 S $13.00 $39 I/I (3) 28,802 0 -
INCY Incyte Corp Director   –       •       •   2008-01-10 4 B $11.01 $33 I/I 3 281,865 2.17 -
INCY Incyte Corp Director   –       •       •   2008-12-22 4/A B $3.25 $10 I/I 3 179,345 2.17 -
GHDX Genomic Health Inc Director   –       •       •   2009-05-21 4 B $17.82 $53 I/I 3 194,105 2.17 -
INCY Incyte Corp Director   –       •       •   2008-01-22 4 B $10.62 $42 I/I 4 129,057 2.17 -
SGEN Seagen Inc Director   –       •       •   2008-02-08 4 B $8.94 $36 I/I 4 476,485 2.17 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2007-12-12 4 S $12.25 $61 I/I (5) 94,691 0 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2008-01-07 4 S $13.00 $65 I/I (5) 89,717 0 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2008-01-08 4 S $13.00 $65 I/I (5) 89,712 0 -
INCY Incyte Corp Director   –       •       •   2009-03-03 4 B $2.14 $11 I/I 5 284,444 2.17 -
INCY Incyte Corp Director   –       •       •   2009-03-05 4 B $2.16 $11 I/I 5 284,449 2.17 -
INCY Incyte Corp Director   –       •       •   2008-01-22 4 B $10.62 $74 I/I 7 131,533 2.17 -
VPHM Viropharma Inc 10% Owner   –       –       •   2008-03-14 4 B $8.67 $78 I/I 9 144,112 1.42 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2008-11-24 4 B $0.98 $10 I/I 10 109,716 1.42 -
GHDX Genomic Health Inc Director   –       •       •   2009-05-21 4 B $17.82 $178 I/I 10 194,161 2.17 -
GHDX Genomic Health Inc Director   –       •       •   2009-08-10 4 B $19.48 $195 I/I 10 194,115 2.17 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-22 4 B $6.92 $76 I/I 11 97,541 1.42 -
INCY Incyte Corp Director   –       •       •   2008-12-22 4/A B $3.25 $39 I/I 12 3,475,852 2.17 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2008-01-10 4 S $13.00 $169 I/I (13) 28,721 0 -
GHDX Genomic Health Inc Director   –       •       •   2009-08-12 4 B $19.70 $276 I/I 14 194,150 2.17 -
  1397  Records found
  1   2   3  4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50   51   52   53   54   55   56      
  Page 3 of 56  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us